Why a lab tool for studying bacterial DNA replication is not as neutral as assumed

What is it about?

Bacteria, like all living things, have to copy their DNA before they divide into two. Scientists who study how this copying works often need to freeze the process at a particular moment so they can count what is happening inside the cell. To do this, they use a long-established laboratory method that relies on two drugs: one to stop the bacteria starting any new copying, and another – the antibiotic cephalexin – to stop the cells dividing, so that everything stays neatly packaged inside one elongated cell where it can be measured. The assumption behind this method is that cephalexin simply prevents the cell from dividing and does nothing else of consequence. We found that this assumption is not quite right. On its own, cephalexin does considerably more than stop cells dividing: it is a genuine antibiotic that eventually kills the cell, and along the way it actually increases the amount of DNA copying going on – the very thing the method is trying to measure. In other words, one of the tools used to study the process turns out to disturb it. The reassuring news is that when both drugs are used together, as they are in the standard method, the second drug largely cancels out this effect, so decades of previous work using the technique are unlikely to be wrong. But not completely: a small fraction of cells still behave unexpectedly. Our study is a reminder that the tools scientists reach for are rarely as neutral as they assume, and that this one deserves a little more care – particularly in the increasingly common experiments that look at single cells one at a time, where a small oddity does not simply average away.

Featured Image

Photo by Nastya Dulhiier on Unsplash

Photo by Nastya Dulhiier on Unsplash

Why is it important?

Scientific results are only as trustworthy as the methods used to obtain them. When a technique has been relied upon for decades, it is easy to stop questioning what its individual parts are actually doing – and that is exactly when a hidden assumption can quietly distort the picture. This study is a concrete example: a drug that everyone treated as a passive helper turned out to be an active participant, affecting the very process under investigation. For the researchers who use this particular method, the practical message is reassuring but important. The technique remains sound for most purposes, but its results should be interpreted with more care in certain situations – especially in modern experiments that examine bacteria one cell at a time, or that use genetically sensitive strains, where a small irregularity can no longer be assumed to cancel itself out. Knowing this helps prevent misleading conclusions before they are drawn. There is also a broader point that reaches beyond bacteriology. The same drug, cephalexin, belongs to one of the most widely prescribed families of antibiotics. Understanding that it does more to bacterial cells than simply stopping them dividing – including triggering additional DNA activity and killing cells – adds to our wider understanding of how antibiotics actually affect the bacteria they target. As concern grows about antibiotic resistance, a clearer picture of what these drugs really do, at the level of the individual cell, is more valuable than ever.

Perspectives